User Manual

Table Of Contents
Glossary
166
Haz
ard alarm
Notification by the PDM that a dangerous condition exis
ts.
Healthcare provider
A professional who practices medicine or teaches people how to
manage their health. All healthcare providers are a resource for
valuable diabetes management information.
Hemoglobin A1c (HbA1c)
A test that measures a persons average blood glucose level over
the past 2 to 3 months. Also called glycosylated hemoglobin, the
test shows the amount of glucose that sticks to the red blood cell,
which is proportional to the amount of glucose in the blood.
Hyperglycemia (high blood glucose)
A higher-than-normal level of glucose in the blood; generally 180
mg/dL or higher.
Hypoglycemia (low blood glucose)
A lower-than-normal level of gluc
ose in the blood; generally 70
mg/dL or lower.
Hypoglycemia unawareness
A condition in which a person does not feel or recognize the
symptoms of hypoglycemia.
Infusing
Introducing a liquid substance under the skin into the
body.
Infusion site
A place on the body where an infusion set or Pod is placed and
cannula is inserted.
Insulin
A hormone that helps the body use glucose for energy. The beta
cells of a healthy pancreas make insulin.
Insulin on board (IOB) (active insulin)
The amount of insulin that is still active in the body from a previ-
ous bolus dose. In the OmniPod System, insulin on board (IOB) is
considered in two parts: the Insulin on Board (IOB) from a previ-
ous correction bolus and the IOB from a previous meal bolus.
The amount of time insulin remains on board” or active
depends on each individuals duration of insulin action. Talk with
your healthcare provider to determine your duration of insulin
action.
The OmniPod System continually calculates the Insulin on Board
(IOB) to help prevent stackingof bolus doses, which is a major
cause of hypoglycemia.
Insulin reaction (see hypoglycemia)